Toft Group Executive Search Successfully Places Jessica M. Riley, Ph.D. as Vice President of Companion Diagnostics at PathAI in Boston, MA

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Jessica M. Riley, Ph.D. as Vice President of Companion Diagnostics at PathAI in Boston, MA.

Dr. Jessica Riley served as Senior Director, Business Development at Guardant Health where she led business collaborations with Pharmaceutical companies for the development and commercialization of Next Generation Sequencing Liquid Biopsy products, as well as Companion Diagnostic programs. She joined Guardant from Leica Biosystems where she served as Senior Director, Business Development, Pharma Partnerships. Previously, Dr. Riley held progressive roles with Qiagen, most recently as Director of Assay Development. 

Dr. Riley’s career began at St. James’s University Hospital as a Clinical Genetics Scientist. She holds a Ph.D. in Bio-production & Characterization of Self-Assembling Peptides from the University of Leeds, UK, and a B.S in Molecular & Cellular Biology from the University of Huddersfield, UK.

About PathAI
PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning. Based in Boston, PathAI works with leading life sciences companies and researchers to advance precision medicine. 

About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego and Boston.